{"id":"https://openalex.org/W2915813634","doi":"https://doi.org/10.1182/blood-2018-11-852491","title":"Fostamatinib for the treatment of chronic immune thrombocytopenia","display_name":"Fostamatinib for the treatment of chronic immune thrombocytopenia","publication_year":2019,"publication_date":"2019-02-25","ids":{"openalex":"https://openalex.org/W2915813634","doi":"https://doi.org/10.1182/blood-2018-11-852491","mag":"2915813634","pmid":"https://pubmed.ncbi.nlm.nih.gov/30803989"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-11-852491","doi":"https://doi.org/10.1182/blood-2018-11-852491","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2018-11-852491","pdf_url":"https://ashpublications.org/blood/article-pdf/133/19/2027/1553337/blood852491.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/133/19/2027/1553337/blood852491.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081768317","display_name":"Nathan T. Connell","orcid":"https://orcid.org/0000-0003-4100-7826","observed_orcids":["https://orcid.org/0000-0003-4100-7826"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathan T. Connell","raw_affiliation_strings":["Harvard Medical School, Boston, MA","Hematology Division, Brigham and Women\u2019s Hospital, Boston, MA; and"],"raw_orcid":"https://orcid.org/0000-0003-4100-7826","affiliations":[{"raw_affiliation_string":"Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Hematology Division, Brigham and Women\u2019s Hospital, Boston, MA; and","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064643623","display_name":"Nancy Berliner","orcid":"https://orcid.org/0000-0001-7502-6895","observed_orcids":["https://orcid.org/0000-0001-7502-6895"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy Berliner","raw_affiliation_strings":["Harvard Medical School, Boston, MA","Hematology Division, Brigham and Women\u2019s Hospital, Boston, MA; and"],"raw_orcid":"https://orcid.org/0000-0001-7502-6895","affiliations":[{"raw_affiliation_string":"Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Hematology Division, Brigham and Women\u2019s Hospital, Boston, MA; and","institution_ids":["https://openalex.org/I1283280774"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":7.6592,"has_fulltext":true,"cited_by_count":111,"citation_normalized_percentile":{"value":0.9799515,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"133","issue":"19","first_page":"2027","last_page":"2030"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11660","display_name":"Blood groups and transfusion","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12352","display_name":"Heparin-Induced Thrombocytopenia and Thrombosis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fostamatinib","display_name":"fostamatinib","score":1.0},{"id":"https://openalex.org/keywords/chronic-immune-thrombocytopenic-purpura","display_name":"chronic ITP","score":0.9929999709129333},{"id":"https://openalex.org/keywords/spleen-tyrosine-kinase-inhibitor","display_name":"spleen tyrosine kinase inhibitor","score":0.9549999833106995},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.8059999942779541},{"id":"https://openalex.org/keywords/clinical-efficacy","display_name":"clinical efficacy","score":0.6650000214576721},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9100000262260437},{"id":"https://openalex.org/keywords/cost-comparison","display_name":"cost comparison","score":0.6449999809265137}],"concepts":[{"id":"https://openalex.org/C2993327898","wikidata":"https://www.wikidata.org/wiki/Q638729","display_name":"Immune thrombocytopenia","level":3,"score":0.9064997434616089},{"id":"https://openalex.org/C2776915898","wikidata":"https://www.wikidata.org/wiki/Q1235195","display_name":"Romiplostim","level":5,"score":0.5862013101577759},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5834397673606873},{"id":"https://openalex.org/C2780588981","wikidata":"https://www.wikidata.org/wiki/Q411588","display_name":"Eltrombopag","level":4,"score":0.5639340877532959},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.45207029581069946},{"id":"https://openalex.org/C2777863708","wikidata":"https://www.wikidata.org/wiki/Q424519","display_name":"Thrombopoietin","level":4,"score":0.3292095363140106},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.31396180391311646},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1597115695476532},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.08542275428771973},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016553","descriptor_name":"Purpura, Thrombocytopenic, Idiopathic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1182/blood-2018-11-852491","doi":"https://doi.org/10.1182/blood-2018-11-852491","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2018-11-852491","pdf_url":"https://ashpublications.org/blood/article-pdf/133/19/2027/1553337/blood852491.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:30803989","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30803989","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1182/blood-2018-11-852491","doi":"https://doi.org/10.1182/blood-2018-11-852491","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2018-11-852491","pdf_url":"https://ashpublications.org/blood/article-pdf/133/19/2027/1553337/blood852491.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2915813634.pdf","grobid_xml":"https://content.openalex.org/works/W2915813634.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W941376371","https://openalex.org/W1570354759","https://openalex.org/W1685983680","https://openalex.org/W1977189730","https://openalex.org/W1979648177","https://openalex.org/W1984073642","https://openalex.org/W1991437102","https://openalex.org/W1994420770","https://openalex.org/W2000853637","https://openalex.org/W2009389738","https://openalex.org/W2027769902","https://openalex.org/W2033207183","https://openalex.org/W2075090852","https://openalex.org/W2084718852","https://openalex.org/W2095255852","https://openalex.org/W2095726706","https://openalex.org/W2102794876","https://openalex.org/W2104778351","https://openalex.org/W2118084423","https://openalex.org/W2158928008","https://openalex.org/W2165983936","https://openalex.org/W2227220935","https://openalex.org/W2312678770","https://openalex.org/W2342664814","https://openalex.org/W2520058836","https://openalex.org/W2763817611","https://openalex.org/W2799711263","https://openalex.org/W2914494465","https://openalex.org/W4210640664"],"related_works":["https://openalex.org/W6958318096","https://openalex.org/W2889135496","https://openalex.org/W2799711263","https://openalex.org/W4400682433","https://openalex.org/W3091853600","https://openalex.org/W4310114200","https://openalex.org/W4310105148","https://openalex.org/W2763817611","https://openalex.org/W4387241571","https://openalex.org/W2997508771"],"abstract_inverted_index":{"Fostamatinib":[0],"is":[1],"a":[2],"spleen":[3],"tyrosine":[4],"kinase":[5],"inhibitor":[6],"recently":[7],"approved":[8],"for":[9,77],"the":[10,68],"treatment":[11],"of":[12,28,35,70],"chronic":[13,78],"immune":[14],"thrombocytopenia":[15],"(ITP)":[16],"in":[17,43,52,72],"patients":[18],"without":[19],"adequate":[20],"response":[21],"to":[22,74],"at":[23],"least":[24],"1":[25],"prior":[26],"line":[27],"therapy.":[29],"This":[30],"article":[31],"reviews":[32],"fostmatinib's":[33],"mechanism":[34],"action":[36],"and":[37,41,56,59],"its":[38],"clinical":[39],"safety":[40],"efficacy":[42],"2":[44],"industry-sponsored":[45],"multicenter":[46],"phase":[47],"3":[48],"randomized":[49],"controlled":[50],"trials":[51],"North":[53],"America,":[54],"Australia,":[55],"Europe":[57],"(FIT1":[58],"FIT2).":[60],"Cost":[61],"comparisons":[62],"are":[63],"discussed":[64],"as":[65,67],"well":[66],"role":[69],"fostamatinib":[71],"relation":[73],"other":[75],"options":[76],"ITP.":[79]},"counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":17},{"year":2024,"cited_by_count":26},{"year":2023,"cited_by_count":16},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2019-03-02T00:00:00"}